Title: Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early Rheumatoid Arthritis: week 16 results from the randomized multicenter CareRA trial
Authors: Verschueren, Patrick *
De Cock, Diederik * ×
Corluy, Luk
Joos, Rik
Langenaken, Christine
Taelman, Veerle
Raeman, Frank
Ravelingien, Isabelle
Vandevyvere, Klaas
Lenaerts, Jan
Geens, Elke
Geusens, Piet
Vanhoof, Johan
Durnez, Anne
Remans, Jan
Vander Cruyssen, Bert
Van Essche, Els
Sileghem, An
De Brabanter, Griet
Joly, Johan
Van der Elst, Kristien
Meyfroidt, Sabrina
Westhovens, Rene #
Issue Date: Apr-2015
Publisher: BioMed Central Ltd.
Series Title: Arthritis Research & Therapy vol:Ahead of print issue:1 pages:97
Abstract: Considering a lack of efficacy data in patients with early Rheumatoid Arthritis (eRA) presenting without classical poor prognosis markers, we compared methotrexate (MTX) with or without step-down glucocorticoids in the Care for early RA (CareRA) trial.
ISSN: 1478-6354
Publication status: accepted
KU Leuven publication type: IT
Appears in Collections:Skeletal Biology and Engineering Research Center (+)
Academic Centre for Nursing and Midwifery
* (joint) first author
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Patients lacking.pdf Published 593KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science